The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $588,880 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to develop fast and accurate methods for reconstructing 3D fetal brain volumes from 2D MRI scans. The goal is to integrate these coherent 3D brain volumes and automated brain biometric...
This federal Project Grant award for $103,441, awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop and validate a rapid, distortion- and blurring-free, and motion- and B0-robust technique for submillimeter-resolution T2* and quantitative susceptibility mapping (QSM) quantification. The project, titled "Fast and Robust...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $249,000 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The Regents of the University of Colorado. The grant will fund the development of a next-generation photoacoustic computed tomography through an ergodic relay (PACTER) device for non-invasive monitoring of cerebral metabolic rate of oxygen. The project aims to address the...
This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
This $884,573 federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is supporting the development of a fast, comprehensive brain MRI technique. The goal is to reduce exam duration by roughly three-fold while capturing quantitative and qualitative MRI contrasts, as well as gadolinium-based enhancement. The project is being led by...
This $537,730 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop advanced in vivo magnetic resonance imaging (MRI) technologies for studying infant brain development. The primary objectives are to achieve motion-robust, high-resolution (600mm isotropic) whole-brain quantitative MRI (qMRI) and diffusion MRI (dMRI) within clinically feasible scan...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $1,244,260.00 to New York University (NYU) to develop an advanced interferometric diffuse optics (IDO) system for quantitatively and specifically measuring cerebral blood flow. The goal is to create a system that can improve the signal-to-noise ratio and channel...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $530,511 to the University of North Carolina at Chapel Hill to continue development of the Infant Brain Extraction and Analysis Toolbox (IBEAT), an advanced deep learning-based software suite for analyzing infant neuroimaging data. The key objectives are to: 1) create...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,360,447.52 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop and evaluate an inexpensive, lightweight "brain monitor" device using magnetic resonance imaging (MRI) technology. The goal is to create a portable MRI-based...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (DMRI) technologies. The project aims to overcome key challenges with current DMRI methods, including lack of sensitivity to detect...